Stanford Medicine has developed nuclei.io, a customizable AI tool that helps pathologists identify diseased cells with greater speed and accuracy.
Main Points:
Pathologists using nuclei.io were 62% faster and 72% more accurate.
The tool is designed to work alongside doctors, not replace them.
It can be customized by individual pathologists without technical expertise.
Summary:
Stanford Medicine has introduced nuclei.io, an AI tool that aids pathologists in identifying diseased cells in tissue samples. Unlike other AI tools, nuclei.io can be customized by individual pathologists based on their workflow and preferences, providing a more personalized diagnostic assistant. In trials, the tool significantly increased the speed and accuracy of diagnoses for conditions such as endometritis and metastatic colon cancer.
The tool learns from pathologists’ feedback, allowing it to improve over time. This innovation aims to address the shortage of pathologists and enhance patient care by providing faster and more precise diagnostic capabilities.
